This article was originally published in The Tan Sheet
FDA's TSE Advisory Committee will examine interim results of new study on inactivation of infective agent by gelatin manufacturing processes June 29 at Holiday Inn, Bethesda, Md., from 8:00 a.m. to 11:30 a.m
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC